Peppy secures $45m Series B funding round

Image source: Peppy’s website

Peppy, the leading health app that connects employees to real, human health experts, has announced today that they have secured a $45m Series B funding round.


The company will use it to support rapid expansion in the US and solidify its position as the global leader in gender-based healthcare. Dr Mridula Pore, co-founder and co-CEO of Peppy, said:

“When we launched Peppy in 2018, I don’t think any of us could quite have anticipated how incredible the next few years would be. Peppy has seen some huge milestones reached, with the latest being news of our series B funding. This funding allows us to accelerate our expansion into the US, and continue to grow in the UK and elsewhere, bringing personalised care and 121 support from real human health experts, to even more people.”


“The Peppy team has executed above all expectations, giving us confidence that Peppy will go on to be the global category leader in providing personalised expert-led pre-clinical care to all” - Jay Wilson, Investment Director at AlbionVC.

Peppy was founded by three like-minded individuals, Mridula Pore, Evan Harris and Max Landry, who all experienced the ‘Oh wow!’ moment of bringing a baby home for the first time.

They saw an opportunity to offer a solution for organisations looking to better support their people, and to differentiate themselves in a hyper-competitive market for talent. And so Peppy was born.

Today, Peppy helps over one million employees, across the private and public sectors. Working with hundreds of organisations to give their employees access to remote, specialist support during some of the most underserved areas of health. This is healthcare at work.

Read more about it in Peppy’s latest blog post here.


Interested in sharing your story on our blog? Become our business member and get visibility in front of our global community through promotion on our social media channels, newsletter, and our website.

Join the community!

Anja StreicherComment